111 related articles for article (PubMed ID: 21658411)
1. Enzyme-linked immunosorbent assays for α-synuclein with species and multimeric state specificities.
Lee HJ; Bae EJ; Jang A; Ho DH; Cho ED; Suk JE; Yun YM; Lee SJ
J Neurosci Methods; 2011 Aug; 199(2):249-57. PubMed ID: 21658411
[TBL] [Abstract][Full Text] [Related]
2. Sensitive and specific detection of α-synuclein in human plasma.
Tinsley RB; Kotschet K; Modesto D; Ng H; Wang Y; Nagley P; Shaw G; Horne MK
J Neurosci Res; 2010 Sep; 88(12):2693-700. PubMed ID: 20648655
[TBL] [Abstract][Full Text] [Related]
3. Production of a monoclonal antibody, against human α-synuclein, in a subpopulation of C57BL/6J mice, presenting a deletion of the α-synuclein locus.
Mougenot AL; Bétemps D; Hogeveen KN; Kovacs GG; Chouaf-Lakhdar L; Milhavet O; Lehmann S; Legastelois S; Pin JJ; Baron TG
J Neurosci Methods; 2010 Oct; 192(2):268-76. PubMed ID: 20709102
[TBL] [Abstract][Full Text] [Related]
4. An antibody with high reactivity for disease-associated α-synuclein reveals extensive brain pathology.
Kovacs GG; Wagner U; Dumont B; Pikkarainen M; Osman AA; Streichenberger N; Leisser I; Verchère J; Baron T; Alafuzoff I; Budka H; Perret-Liaudet A; Lachmann I
Acta Neuropathol; 2012 Jul; 124(1):37-50. PubMed ID: 22370907
[TBL] [Abstract][Full Text] [Related]
5. Detection of oligomeric forms of alpha-synuclein protein in human plasma as a potential biomarker for Parkinson's disease.
El-Agnaf OM; Salem SA; Paleologou KE; Curran MD; Gibson MJ; Court JA; Schlossmacher MG; Allsop D
FASEB J; 2006 Mar; 20(3):419-25. PubMed ID: 16507759
[TBL] [Abstract][Full Text] [Related]
6. Immunochemical Detection of α-Synuclein Autoantibodies in Parkinson's Disease: Correlation between Plasma and Cerebrospinal Fluid Levels.
Horvath I; Iashchishyn IA; Forsgren L; Morozova-Roche LA
ACS Chem Neurosci; 2017 Jun; 8(6):1170-1176. PubMed ID: 28263550
[TBL] [Abstract][Full Text] [Related]
7. ELISA method to detect α-synuclein oligomers in cell and animal models.
Lassen LB; Gregersen E; Isager AK; Betzer C; Kofoed RH; Jensen PH
PLoS One; 2018; 13(4):e0196056. PubMed ID: 29698510
[TBL] [Abstract][Full Text] [Related]
8. Cerebrospinal fluid Tau/α-synuclein ratio in Parkinson's disease and degenerative dementias.
Parnetti L; Chiasserini D; Bellomo G; Giannandrea D; De Carlo C; Qureshi MM; Ardah MT; Varghese S; Bonanni L; Borroni B; Tambasco N; Eusebi P; Rossi A; Onofrj M; Padovani A; Calabresi P; El-Agnaf O
Mov Disord; 2011 Jul; 26(8):1428-35. PubMed ID: 21469206
[TBL] [Abstract][Full Text] [Related]
9. Cerebrospinal fluid alpha-synuclein in neurodegenerative disorders-a marker of synapse loss?
Ohrfelt A; Grognet P; Andreasen N; Wallin A; Vanmechelen E; Blennow K; Zetterberg H
Neurosci Lett; 2009 Feb; 450(3):332-5. PubMed ID: 19022350
[TBL] [Abstract][Full Text] [Related]
10. Development of electrochemiluminescence-based singleplex and multiplex assays for the quantification of α-synuclein and other proteins in cerebrospinal fluid.
Kruse N; Schulz-Schaeffer WJ; Schlossmacher MG; Mollenhauer B
Methods; 2012 Apr; 56(4):514-8. PubMed ID: 22465793
[TBL] [Abstract][Full Text] [Related]
11. Determination of alpha-synuclein concentration in human plasma using ELISA.
Fjorback AW; Varming K; Jensen PH
Scand J Clin Lab Invest; 2007; 67(4):431-5. PubMed ID: 17558898
[TBL] [Abstract][Full Text] [Related]
12. Red blood cells are the major source of alpha-synuclein in blood.
Barbour R; Kling K; Anderson JP; Banducci K; Cole T; Diep L; Fox M; Goldstein JM; Soriano F; Seubert P; Chilcote TJ
Neurodegener Dis; 2008; 5(2):55-9. PubMed ID: 18182779
[TBL] [Abstract][Full Text] [Related]
13. Different sub-cellular localization of alpha-synuclein in the C57BL\6J mouse's central nervous system by two novel monoclonal antibodies.
Vivacqua G; Casini A; Vaccaro R; Fornai F; Yu S; D'Este L
J Chem Neuroanat; 2011 Mar; 41(2):97-110. PubMed ID: 21172422
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring α-synuclein autoantibody levels are lower in patients with Parkinson disease.
Besong-Agbo D; Wolf E; Jessen F; Oechsner M; Hametner E; Poewe W; Reindl M; Oertel WH; Noelker C; Bacher M; Dodel R
Neurology; 2013 Jan; 80(2):169-75. PubMed ID: 23255825
[TBL] [Abstract][Full Text] [Related]
15. Aggregated alpha-synuclein activates microglia: a process leading to disease progression in Parkinson's disease.
Zhang W; Wang T; Pei Z; Miller DS; Wu X; Block ML; Wilson B; Zhang W; Zhou Y; Hong JS; Zhang J
FASEB J; 2005 Apr; 19(6):533-42. PubMed ID: 15791003
[TBL] [Abstract][Full Text] [Related]
16. Alpha-synuclein implicated in Parkinson's disease is present in extracellular biological fluids, including human plasma.
El-Agnaf OM; Salem SA; Paleologou KE; Cooper LJ; Fullwood NJ; Gibson MJ; Curran MD; Court JA; Mann DM; Ikeda S; Cookson MR; Hardy J; Allsop D
FASEB J; 2003 Oct; 17(13):1945-7. PubMed ID: 14519670
[TBL] [Abstract][Full Text] [Related]
17. Fine epitope mapping of monoclonal antibodies specific to human alpha-synuclein.
Choi JY; Park HJ; Seong YM; Choi EY; Min BR; Rhim H
Neurosci Lett; 2006 Apr 10-17; 397(1-2):53-8. PubMed ID: 16380207
[TBL] [Abstract][Full Text] [Related]
18. Total α-synuclein levels in human blood cells, CSF, and saliva determined by a lipid-ELISA.
Abd-Elhadi S; Basora M; Vilas D; Tolosa E; Sharon R
Anal Bioanal Chem; 2016 Nov; 408(27):7669-7677. PubMed ID: 27624766
[TBL] [Abstract][Full Text] [Related]
19. Non-classical exocytosis of alpha-synuclein is sensitive to folding states and promoted under stress conditions.
Jang A; Lee HJ; Suk JE; Jung JW; Kim KP; Lee SJ
J Neurochem; 2010 Jun; 113(5):1263-74. PubMed ID: 20345754
[TBL] [Abstract][Full Text] [Related]
20. Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein.
Lee HJ; Suk JE; Bae EJ; Lee JH; Paik SR; Lee SJ
Int J Biochem Cell Biol; 2008; 40(9):1835-49. PubMed ID: 18291704
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
